Sarizotan HC1 ( DrugBank: Sarizotan )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00105508 (ClinicalTrials.gov)	September 30, 2004	15/3/2005	Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia	A Double-blind, Placebo-controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan HCl 1 mg b.i.d. in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia	Parkinson's Disease;Dyskinesia	Drug: Sarizotan;Drug: Placebo	EMD Serono	NULL	Completed	30 Years	N/A	All	506	Phase 3	United States
2	NCT00105521 (ClinicalTrials.gov)	September 2004	15/3/2005	Sarizotan HCl in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia	A Double-blind, Placebo-controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan HCl 1 mg b.i.d. in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia	Parkinson's Disease;Dyskinesia	Drug: Sarizotan HC1	EMD Serono	NULL	Completed	30 Years	N/A	All	594	Phase 3	United States